Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

Weight loss jabs such as Wegovy and Mounjaro are being used by an estimated 1.6 million adults in Great Britain per year, ...

Chances are you've heard that the GLP-1s called semaglutide (Ozempic and Wegovy) and liraglutide (Victoza and Saxenda), used for weight management and/or control of Type 2 diabetes, are also good for ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

In early 2025, around 4.9 million British adults - almost one in ten - are estimated to have recently used, or expressed ...

Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight ...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

Weight and heart benefits were fully reversed within 2 years of stopping weight-loss medications. Patients regained about 0.9 ...

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight ...

Experts say OADs, insulin to dominate anti-diabetes market, with semaglutide patent loss leading to possible price erosion, ...